Investors
Z眉rcher Kantonal Bank
Z眉rcher Kantonal Bank (ZKB) is one of Switzerland's largest banks, managing over CHF 400 billion in client assets. With a top credit rating, ZKB supports early-stage startups in sectors like Health Tech and Biotech, investing in Seed to Series B rounds. Notable investments include RetinAI Medical and Hemotune. Since 2005, ZKB has invested more than CHF 220 million in over 260 startups. In addition to venture funding, the bank offers services in financing, asset management, and retirement planning, balancing economic goals with environmental and social initiatives.
Recent Investments
- QumeaSeries A(
28 ) - HemotuneSeries B( 37 )
- Artiria MedicalSeries A( 28 )
- MicrocapsSeries A( 37 )
- RetinAI MedicalSeries A( 31 )
- AesyraSeed( 21 )
- Onena MedicinesSeed( 21 )
- AvaSeed( 33 )
- Memo TherapeuticsSeries A( 37 )
- ClimeworksSeries B( 52 )